R. Guévin

发表

Phase III trial comparing granulocyte colony-stimulating factor to leridistim in the prevention of neutropenic complications in breast cancer patients treated with docetaxel/doxorubicin/cyclophosphamide: results of the BCIRG 004 trial.

J. Mackey, P. Vodvářka, A. Riva, 2002, Clinical breast cancer.

Phase III double-blind comparison of dolasetron mesylate and ondansetron and an evaluation of the additive role of dexamethasone in the prevention of acute and delayed nausea and vomiting due to moderately emetogenic chemotherapy.

J. Hainsworth, B. Zee, J. Krook, 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The role of the 5-HT3 antagonists ondansetron and dolasetron in the control of delayed onset nausea and vomiting in patients receiving moderately emetogenic chemotherapy.

J. Hainsworth, J. Krook, D. Walde, 1997, Annals of oncology : official journal of the European Society for Medical Oncology.

[The NSABP. National Surgical Adjuvant Project for Breast and Bowel Cancers. (Definition, role, methodology, therapeutic trials, results, philosophy)].

B. Fisher, R. Poisson, L. Perron, 1985, L'union medicale du Canada.

Detection of surface and core antigens of hepatitis B virus in the liver of 164 human subjects. A study by immunoperoxidase and orcein staining.

J. Cǒté, F. Lamothe, A. Viallet, 1976, Gastroenterology.

Adjuvant docetaxel for node-positive breast cancer.

Marek Pawlicki, John Hainsworth, Matthieu Rupin, 2005, The New England journal of medicine.

Chronic carriers of hepatitis B antigen (HBsAg)

J. Villeneuve, J. Cǒté, D. Marleau, 2005, The American Journal of Digestive Diseases.

Severe alloimmune neonatal thrombocytopenia due to specific HLA antibodies.

M. Sternbach, R. Guévin, F. Nadon, 1986, Current studies in hematology and blood transfusion.

Another Example of Lewis Negative Bombay Bloods

R. Guévin, H. M. Pretty, V. Taliano, 1969, Vox sanguinis.

Hepatosensitization caused by propionyl erythromycin lauryl sulfate.

R. Guévin, A. ten Pas, 1963, Henry Ford Hospital medical bulletin.

Hepatitis B antigen in Montréal blood donors: childhood institutionalization as an epidemiologic factor.

M. Desrochers, A. Viallet, R. Guévin, 1975, Canadian Medical Association journal.

Australia Antigen ‘ad’ and ‘ay’ Subtypes. Purification and Partial Characterization

R. Bourbonnais, R. Guévin, E. E. Delvin, 1975, Vox sanguinis.

Difference in the distribution of e antigen among different ethnic groups in a population of blood donors.

D. Phaneuf, A. Viallet, R. Guévin, 1977, Canadian Medical Association journal.

Randomized phase III study of fludarabine phosphate versus cyclophosphamide, vincristine, and prednisone in patients with recurrent low-grade non-Hodgkin's lymphoma previously treated with an alkylating agent or alkylator-containing regimen.

C. Sawka, C. Shustik, R. Meyer, 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Adjuvant Docetaxel plus Doxorubicin and Cyclophosphamide for Node-Positive Breast Cancer

A. Howell, J. Hainsworth, J. Mackey, 2005 .

The importance of dose scheduling with mitoxantrone, 5-fluorouracil and leucovorin in metastatic breast cancer.

K. Bélanger, L. Yelle, J. Latreille, 1994, European Journal of Cancer.

The Rare Phenotype En(a‐) in a French‐Canadian Family

D. Anstee, P. Tippett, W. Mawby, 1980, Vox sanguinis.

The Genetics of a Dominant Inhibitor of the Lutheran Antigens

P. Tippett, R. Guévin, V. Taliano, 1973, Vox sanguinis.